MT-3995

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for MT-3995, covering 2015-01-27 to 2019-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) [Phase 2]